Bioventix (AIM:BVXP) record results from this unusual high margin offering
We published a detailed commentary on this back in April 2015 which is worth a read.
For the year to 30th June 2015 revenue was up 23% to £4.3m and pre-tax profit up 39% to £3.1m (2013/14: £2.2m). The operating cash inflow was also a majestic £2.915m with free cash flow £2m after a modest £113k of capex. Year-end cash was £4.13m after the payment of equity…
Sign up and read the full article
Register to continue reading our content.
Already a member? Login
Previous article Next article